.jpg)
1 hour ago
3
Article content
CARLSBAD, Calif., May 07, 2026 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in the development of groundbreaking medical devices for spinal surgery, today announced the issuance of its fourth U.S. patent related to Aurora’s proprietary DEXA Technology® platform.
THIS CONTENT IS RESERVED FOR SUBSCRIBERS ONLY
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman, and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
SUBSCRIBE TO UNLOCK MORE ARTICLES
Subscribe now to read the latest news in your city and across Canada.
- Exclusive articles from Barbara Shecter, Joe O'Connor, Gabriel Friedman and others.
- Daily content from Financial Times, the world's leading global business publication.
- Unlimited online access to read articles from Financial Post, National Post and 15 news sites across Canada with one account.
- National Post ePaper, an electronic replica of the print edition to view on any device, share and comment on.
- Daily puzzles, including the New York Times Crossword.
REGISTER / SIGN IN TO UNLOCK MORE ARTICLES
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account.
- Share your thoughts and join the conversation in the comments.
- Enjoy additional articles per month.
- Get email updates from your favourite authors.
THIS ARTICLE IS FREE TO READ REGISTER TO UNLOCK.
Create an account or sign in to continue with your reading experience.
- Access articles from across Canada with one account
- Share your thoughts and join the conversation in the comments
- Enjoy additional articles per month
- Get email updates from your favourite authors
Sign In or Create an Account
or
Article content
The newly issued patent, U.S. Patent No. 12,605,252 B2, titled “Bone Density Scan Result-Matched Orthopedic Implants and Methods of Use,” was issued on April 21, 2026, and further strengthens Aurora Spine’s intellectual property portfolio surrounding patient-specific, bone density-matched implant selection and use.
Article content
Article content
Article content
The patented technology describes methods for obtaining a patient’s bone density information, including a DEXA T-score or bone density measurement, selecting an implant having a density level matched to the patient’s native bone at the implantation site, and implanting the selected device. The patent further supports Aurora’s broader DEXA Technology platform, which is designed to provide surgeons with implants engineered to better match patient bone quality, including low, mid, and high bone-density implant options.
Article content
By signing up you consent to receive the above newsletter from Postmedia Network Inc.
Article content
“This fourth issued DEXA Technology patent represents another important milestone in Aurora Spine’s strategy to protect and expand our leadership in bone density-matched spinal implant innovation,” said Trent J. Northcutt, President and CEO of Aurora Spine. “DEXA Technology was created to address a real clinical challenge: patients do not all have the same bone quality. By giving surgeons implant options designed around bone density, we believe Aurora is advancing a more personalized and intelligent approach to spine surgery. Through the issuance of this patent, Aurora’s competitive position will improve and it support continued development of next-generation DEXA Technology-based implants across the Company’s spinal implant portfolio.”
Article content
Article content
Aurora’s DEXA Technology platform was developed to improve the relationship between implant structure and patient bone quality. By offering implants with density-matched characteristics, Aurora aims to help surgeons select devices that may better align with the mechanical environment of each patient’s anatomy.
Article content
“This patent further validates years of research and development focused on matching implant architecture to patient bone density,” said Laszlo Garamszegi, Chief Technology Officer of Aurora Spine. “The invention protects important methods for using bone density information to guide implant selection, which is central to our DEXA platform. We believe this approach has the potential to support better load sharing, reduce implant-related complications associated with poor bone quality, and help surgeons make more informed intraoperative decisions.”
Article content
About Aurora Spine
Article content
Aurora Spine Corporation (TSX Venture: ASG | OTCQB: ASAPF) is an innovative designer and manufacturer of minimally invasive spinal implants and interventional pain management technologies. Headquartered in Carlsbad, California, the company’s mission is to improve spinal surgery outcomes through simplified, integrated, and cost-effective solutions that advance patient care worldwide. Additional information can be accessed at www.aurora-spine.com.
English (US)